Genital abnormalities occur in 4 per cent of male births. These include undescended testicles, malformations of the urinary tract, hypospadias (see Related Resources), prostate damage, reduced sperm production and mobility, Sertoli cell damage (required to support sperm development), Leydig cell tumours.
The European Union has joined with other government regulatory agencies in viewing certain phthalates as a potential hazard for human reproduction. In November 2002, the EU amended the Cosmetics Directive 76/768/EEC to order the removal of two phthalates in because of their reproductive toxicity. This directive should be enacted in the near future.
The European Union had previously classified both phthalates as substances, “…which should be regarded as if they impair fertility in humans” and substances, “…which should be regarded as if they cause developmental toxicity to humans.”
The FDA (Food and Drug Administration) in April 2001 said that they believe that "at the present time there is no reason for consumers to be alarmed at the use of cosmetics containing phthalates". It adds that they will continue to evaluate study data and if a health hazard exists they will consider its legal options under the authority of the Food, Drug and cosmetic Act in protecting the health and welfare of consumers. Their advice remains the same at this present moment in time.
Could this be a good example of the need for labeling of toiletries and cosmetics? At present this is not a general requirement but is perhaps something that we as consumers might choose to lobby more forcefully for?
